Abstract B002: Computational Discovery of Evolutionary Synthetic Lethality Networks for Personalized Gene Therapy and Small-Molecule Design in Treatment-Resistant Pediatric High-Grade Glioma
An integrative computational framework is developed to reconstruct resistance evolution, identify state-specific therapeutic vulnerabilities, and design personalized gene therapy and blood-brain barrier (BBB)-penetrant small-molecule therapeutics targeting treatment-resistant pediatric glioma.